CORRECTION FROM SOURCE: NLS Pharmaceutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
CORRECTION FROM SOURCE: NLS Pharmaceutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
This conference will be live on M-Vest. To attend, just sign up to become an M-Vest member.Presentation to take place on Tuesday, June 20, 2023, at 10:30AM ET
演講將於美國東部時間2023年6月20日星期二上午 10:30 舉行
ZURICH, SWITZERLAND / ACCESSWIRE / June 19, 2023 / NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20, 2023, at 10:30 AM ET.
瑞士蘇黎世/Accesswire/2023 年 6 月 19 日/ 專注於爲罕見和複雜的中樞神經系統疾病患者發現和開發創新療法的瑞士臨床階段生物製藥公司NLS Pharmaceutics Ltd.（納斯達克股票代碼：NLSP，NLSPW）（“NLS” 或 “公司”）今天宣佈，NLS Pharmaceutics首席執行官亞歷克斯·茲威爾將出席由Maxim Group and LLC主辦的醫療保健虛擬會議第二部分由 M-Vest 主辦 美國東部時間 2023 年 6 月 20 日星期二上午 10:30。
The exponential growth in knowledge and expertise in science and medicine continues to drive opportunities in the healthcare space. These include multiple therapeutic categories and emerging technologies, which presenting companies at this year's Maxim Healthcare Conference are focused on, and for many, that includes key data-driven events in 2023. Maxim Senior Analysts will host a wide range of biotechnology and medical device companies in a series of presentations and interactive discussions with CEOs and key management. Maxim will also be hosting several topical industry panels that promise to be timely and engaging.
科學和醫學知識和專業知識的指數級增長繼續推動醫療保健領域的機遇。其中包括多個治療類別和新興技術，在今年的Maxim Healthcare Conference大會上，參展公司重點關注這些類別和新興技術，對許多公司來說，其中包括2023年以數據爲導向的關鍵活動。Maxim高級分析師將與首席執行官和關鍵管理層進行一系列演講和互動討論，邀請衆多生物技術和醫療設備公司參加。Maxim還將主持幾場主題行業小組討論會，這些小組討論有望及時且引人入勝。
This conference will be live on M-Vest. To attend, just sign up to become an M-Vest member.
該會議將在M-Vest上直播。要參加，只需註冊成爲M-Vest會員即可。
Click here to reserve your seat.
點擊此處預訂座位。
About NLS Pharmaceutics Ltd.
關於 NLS 製藥有限公司
NLS Pharmaceutics Ltd. (Nasdaq: NLSP) is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a track record of developing and commercializing product candidates. For more information, please visit .
NLS Pharmaceutics Ltd.（納斯達克股票代碼：NLSP）是一家處於開發階段的全球生物製藥公司，與世界一流的合作伙伴和國際公認的科學家合作，專注於爲醫療需求未得到滿足的罕見覆雜中樞神經系統（CNS）疾病患者發現和開發創新療法。NLS 總部位於瑞士，成立於 2015 年，由一支經驗豐富的管理團隊領導，在開發和商業化候選產品方面有着良好的記錄。欲瞭解更多信息，請訪問。
For additional information:
欲瞭解更多信息：
Marianne Lambertson (investors & media)
NLS Pharmaceutics Ltd.
+1 239.682.8500
ml@nls-pharma.com
瑪麗安·蘭伯森（投資者和媒體）
NLS 製藥有限公司
+1 239.682.8500
ml@nls-pharma.com
SOURCE: NLS Pharmaceutics AG
來源： NLS 製藥股份有限公司